Some interference with fluorimetric determination of urinary porphyrins reported.
Rationale
Competitive CYP-inhibitor. Some clinical experience of tolerance. Conflicting references.
Chemical description
Quinolone antibiotic. About 50% of the dose is excreted in unchanged form by the kidneys. Four metabolites are observed. Competitive inhibitor of several CYPs, possibly also at the transcriptional level.
Personal communication
Thunell, patient inquiry: Used without ill effects (n=1).
Andersson: Used in some patients and well tolerated.
IPNet drug reports
Uneventful use reported in 32 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes
J01M /
J01MA or
go back.
References
#
Citation details
PubMed ID
Porphyria Drug Lists
1.
Australian List
Australian Porphyria Association No longer maintained